Monitoring requirements : Appointments are commonly arranged around dose increases and at approximately 12 weeks after starting treatment
they should not be taken as evidence of equivalent efficacy
The results showed that the overexpression of ATP6AP1L gene with pcDNA3.1-GST DAF -ATP6AP1L and pcDNA3.1-GST CEAM7 -ATP6AP1L could significantly inhibit the proliferation of K-562 cells compared with the control cells transfected with empty vectors, pcDNA3.1-GST DAF, and pcDNA3.1-GST CEAM7 , respectively
Tuy nhin, hiu qu thc s ph thuc vo nhiu yu t: sinh kh dng ca glutathione trong sn phm, liu lng tiu th, v tnh trng sinh hc c nhn (v d: mc oxy ho hin ti ca c th)
Improvements were seen in muscle quality: increases in muscle density (less intramuscular fat) across truncal muscle groups, particularly rectus abdominis (3.5 Hounsfield Units), after 26 weeks